ACADIA Pharmaceuticals Inc. Email & Phone number of top level executives

ACADIA Pharmaceuticals Inc.

Healthcare, Pharmaceuticals, and Biotech

Acadia Pharmaceuticals Inc is a biopharmaceutical company based in the United States that specializes in the development and commercialization of products for the treatment of central nervous system (CNS) disorders. The company has a particular focus on Parkinson's disease, Alzheimer's disease, schizophrenia, and depression. The company's lead product, Nuplazid, is the only FDA-approved treatment for Parkinson's psychosis. The company's pipeline also includes other drug candidates in various stages of development. Acadia Pharmaceuticals is committed to advancing the science behind CNS disorders and improving the lives of those affected by these conditions.